Kurs & Likviditet
Kalender
2024-11-07 | Kvartalsrapport 2024-Q3 |
2024-08-15 | Kvartalsrapport 2024-Q2 |
2024-05-16 | Kvartalsrapport 2024-Q1 |
2024-03-21 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2024-03-20 | Årsstämma 2024 |
2024-02-27 | Bokslutskommuniké 2023 |
2023-11-09 | Kvartalsrapport 2023-Q3 |
2023-08-17 | Kvartalsrapport 2023-Q2 |
2023-05-11 | Kvartalsrapport 2023-Q1 |
2023-03-30 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2023-03-29 | Årsstämma 2023 |
2023-03-02 | Bokslutskommuniké 2022 |
2022-11-10 | Kvartalsrapport 2022-Q3 |
2022-08-11 | Kvartalsrapport 2022-Q2 |
2022-05-12 | Kvartalsrapport 2022-Q1 |
2022-05-09 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2022-04-06 | Årsstämma 2022 |
2022-03-10 | Bokslutskommuniké 2021 |
2021-11-11 | Kvartalsrapport 2021-Q3 |
2021-08-12 | Kvartalsrapport 2021-Q2 |
2021-05-12 | Kvartalsrapport 2021-Q1 |
2021-04-16 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2021-04-15 | Årsstämma 2021 |
2021-03-11 | Bokslutskommuniké 2020 |
2020-11-12 | Kvartalsrapport 2020-Q3 |
2020-08-13 | Kvartalsrapport 2020-Q2 |
2020-05-14 | Kvartalsrapport 2020-Q1 |
2020-04-03 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2020-04-02 | Årsstämma 2020 |
2020-03-12 | Bokslutskommuniké 2019 |
2019-11-14 | Kvartalsrapport 2019-Q3 |
2019-08-15 | Kvartalsrapport 2019-Q2 |
2019-05-16 | Kvartalsrapport 2019-Q1 |
2019-04-05 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2019-04-04 | Årsstämma 2019 |
2019-03-07 | Bokslutskommuniké 2018 |
2018-11-15 | Kvartalsrapport 2018-Q3 |
2018-08-16 | Kvartalsrapport 2018-Q2 |
2018-05-16 | Kvartalsrapport 2018-Q1 |
2018-04-20 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2018-04-19 | Årsstämma 2018 |
2018-03-07 | Bokslutskommuniké 2017 |
2017-11-08 | Kvartalsrapport 2017-Q3 |
2017-08-24 | Kvartalsrapport 2017-Q2 |
2017-05-17 | Kvartalsrapport 2017-Q1 |
2017-04-06 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2017-04-05 | Årsstämma 2017 |
2017-03-15 | Bokslutskommuniké 2016 |
2016-11-09 | Kvartalsrapport 2016-Q3 |
2016-08-25 | Kvartalsrapport 2016-Q2 |
2016-05-18 | Kvartalsrapport 2016-Q1 |
2016-04-20 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2016-04-19 | Årsstämma 2016 |
2016-03-16 | Bokslutskommuniké 2015 |
2015-11-05 | Kvartalsrapport 2015-Q3 |
2015-08-28 | Kvartalsrapport 2015-Q2 |
2015-05-22 | Kvartalsrapport 2015-Q1 |
2015-04-22 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2015-04-21 | Årsstämma 2015 |
2015-03-12 | Bokslutskommuniké 2014 |
2014-11-07 | Kvartalsrapport 2014-Q3 |
2014-08-21 | Kvartalsrapport 2014-Q2 |
2014-05-06 | Kapitalmarknadsdag 2014 |
2014-04-29 | Kvartalsrapport 2014-Q1 |
2014-04-29 | Årsstämma 2014 |
2014-03-21 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2014-03-20 | Bokslutskommuniké 2013 |
2013-11-15 | Kvartalsrapport 2013-Q3 |
2013-08-29 | Kvartalsrapport 2013-Q2 |
2013-05-15 | Kvartalsrapport 2013-Q1 |
2013-04-30 | Årsstämma 2013 |
2013-04-30 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2013-03-14 | Bokslutskommuniké 2012 |
2012-11-29 | Kapitalmarknadsdag 2012 |
2012-04-26 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2012-04-25 | Årsstämma 2012 |
2011-11-17 | Kvartalsrapport 2011-Q3 |
2011-10-25 | Kapitalmarknadsdag 2011 |
2011-08-18 | Kvartalsrapport 2011-Q2 |
2011-05-12 | Kvartalsrapport 2011-Q1 |
2011-04-29 | X-dag ordinarie utdelning ZEAL 0.00 DKK |
2011-04-28 | Årsstämma 2011 |
Beskrivning
Land | Danmark |
---|---|
Lista | Large Cap Copenhagen |
Sektor | Hälsovård |
Industri | Bioteknik |
Press release – No. 3 / 2023
Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference
Copenhagen, Denmark, March 1, 2024 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced that Adam Steensberg, Chief Executive Officer, will present at TD Cowen’s 44th Annual Health Care Conference in Boston on Monday, March 4 at 1:30 – 2:00 p.m. ET (7:30 – 8:00 p.m. CET).
A webcast of the presentation will be available at https://wsw.com/webcast/cowen154/zeal.co/2411784 and accessible through the Events page in the Investor section of Zealand Pharma’s website at https://www.zealandpharma.com/events/ where a replay will also be archived following the presentation.
# # #
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with several pharma companies as well as commercial partnerships for its marketed products.
Zealand was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the U.S. For more information about Zealand’s business and activities, please visit www.zealandpharma.com.
Contact:
Anna Krassowska, PhD
Vice President, Investor Relations & Corporate Communications
Zealand Pharma
Email: ank@zealandpharma.com